TEL: +86 571 56623320    EMAIL: SALES@SUNLONGBIOTECH.COM

Human tyrosine kinase with immunoglobulin-like and EGF-like domains 2,Tie-2 ELISA Kit
Human tyrosine kinase with immunoglobulin-like and EGF-like domains 2,Tie-2 ELISA Kit
Total
(Vip priceV)
Regular members: $374.4
View History [Clear]

Details

Drug Names

Generic NameHuman tyrosine kinase with immunoglobulin-like and EGF-like domains 2 (Tie-2) ELISA Kit

Purpose

Our Human tyrosine kinase with immunoglobulin-like and EGF-like domains 2 (Tie-2) ELISA kit is to assay Tie-2 levels in Human serum, plasma, culture media or any biological fluid.

Principle

This ELISA kit uses Sandwich-ELISA as the method. The Microelisa stripplate provided in this kit has been pre-coated with an antibody specific to Tie-2. Standards or samples are added to the appropriate Microelisa stripplate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for Tie-2 is added to each Microelisa stripplate well and incubated. Free components are washed away. The TMB substrate solution is added to each well. Only those wells that contain Tie-2 and HRP conjugated Tie-2 antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm. The OD value is proportional to the concentration of Tie-2. You can calculate the concentration of Tie-2 in the samples by comparing the OD of the samples to the standard curve.

Bought notes(bought amounts latest0)

No one bought this product
Total 0 records, divided into1 pages First Prev Next Last

User Comment(Total0User Comment Num)

  • No comment
Total 0 records, divided into1 pages First Prev Next Last
Username: Anonymous user
E-mail:
Rank:
Content:
Verification code: captcha

Call us

+86 571 56623320

Address

Room 1-315, Kongle Changqing Building, No. 160 Guangye Road,Gongshu District, Hangzhou City, Zhejiang Province, China

Join Us with

Leave a message
* To protect against spam, please pass the CAPTCHA test below.